Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
VSEE HEALTH, INC. incurred convertible notes of $217,391 with an accredited institutional investor at 18% per annum maturing October 29, 2026.
- Instrument
- convertible notes
- Principal
- $217,391
- Counterparty
- an accredited institutional investor
- Rate
- 18% per annum
- Maturity
- October 29, 2026
- Event
- incurrence
Exact text from the filing
On October 29, 2025, VSee Health, Inc. (the "Company"), entered into a convertible note purchase agreement (the "CNPA") with an accredited institutional investor (the "Investor"), whereby the Investor purchased a convertible promissory note in the initial principal amount of $217,391
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
VSEE HEALTH, INC. issued 50,000 shares of the Company’s common stock of common stock to an accredited institutional investor for aggregate purchase price of $201,000.
- Security
- common stock
- Shares
- 50,000 shares of the Company’s common stock
- Purchaser
- an accredited institutional investor
- Consideration
- aggregate purchase price of $201,000
Exact text from the filing
the Investor purchased a convertible promissory note in the initial principal amount of $217,391 (the “Note”) and 50,000 shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”) for an aggregate purchase price of $201,000.
View on SEC.gov